| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 6.94e-07 | 14 | 105 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 5.92e-06 | 23 | 105 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.55e-05 | 29 | 105 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.55e-05 | 29 | 105 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.96e-05 | 34 | 105 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.13e-05 | 73 | 105 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 7.97e-05 | 196 | 105 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.27e-04 | 49 | 105 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.37e-04 | 149 | 105 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 3.07e-04 | 173 | 105 | 6 | GO:0070851 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 4.05e-04 | 6 | 105 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 4.67e-04 | 29 | 105 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.07e-04 | 70 | 105 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 7.51e-04 | 8 | 105 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.30e-03 | 90 | 105 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.39e-03 | 231 | 105 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.41e-03 | 316 | 105 | 7 | GO:0035091 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 5.65e-07 | 14 | 103 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.67e-07 | 15 | 103 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.67e-07 | 15 | 103 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.67e-07 | 15 | 103 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.67e-07 | 15 | 103 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.02e-06 | 16 | 103 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.33e-06 | 17 | 103 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.33e-06 | 17 | 103 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.33e-06 | 17 | 103 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.70e-06 | 18 | 103 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.67e-06 | 20 | 103 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.94e-06 | 45 | 103 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.29e-06 | 21 | 103 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.29e-06 | 21 | 103 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.29e-06 | 21 | 103 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.00e-06 | 22 | 103 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 4.83e-06 | 23 | 103 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.83e-06 | 23 | 103 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 5.77e-06 | 24 | 103 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 5.77e-06 | 24 | 103 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 5.77e-06 | 24 | 103 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 6.84e-06 | 25 | 103 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 6.84e-06 | 25 | 103 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 9.42e-06 | 27 | 103 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.08e-05 | 151 | 103 | 7 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.09e-05 | 28 | 103 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.14e-05 | 59 | 103 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.24e-05 | 60 | 103 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.27e-05 | 29 | 103 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.66e-05 | 31 | 103 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.89e-05 | 32 | 103 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.89e-05 | 32 | 103 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.89e-05 | 32 | 103 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.15e-05 | 33 | 103 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.15e-05 | 33 | 103 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.31e-05 | 114 | 103 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.42e-05 | 34 | 103 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.42e-05 | 34 | 103 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.46e-05 | 69 | 103 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | LGMN SNX4 DRD2 TUT4 SPI1 DSCAM PSG3 PSG4 PSG6 CASR CFHR4 APOBEC3F CEACAM21 SLIT1 OTOP1 PSG8 LTF BECN1 FEM1A | 2.48e-05 | 1316 | 103 | 19 | GO:0032101 |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.63e-05 | 70 | 103 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.73e-05 | 35 | 103 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.82e-05 | 71 | 103 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 2.82e-05 | 71 | 103 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.02e-05 | 72 | 103 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.80e-05 | 38 | 103 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.22e-05 | 39 | 103 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 4.67e-05 | 40 | 103 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.15e-05 | 41 | 103 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 5.67e-05 | 42 | 103 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 6.73e-05 | 85 | 103 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 8.15e-05 | 46 | 103 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 8.15e-05 | 46 | 103 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | DRD2 TUT4 SPI1 PSG3 PSG4 PSG6 CFHR4 APOBEC3F OTOP1 PSG8 LTF BECN1 | 8.74e-05 | 643 | 103 | 12 | GO:0002831 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 8.87e-05 | 47 | 103 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 8.87e-05 | 47 | 103 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 8.87e-05 | 47 | 103 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 9.32e-05 | 91 | 103 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 9.58e-05 | 147 | 103 | 6 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.03e-04 | 93 | 103 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.03e-04 | 93 | 103 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.05e-04 | 49 | 103 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.05e-04 | 49 | 103 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.13e-04 | 50 | 103 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.14e-04 | 95 | 103 | 5 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.20e-04 | 96 | 103 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.20e-04 | 96 | 103 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.32e-04 | 52 | 103 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.32e-04 | 98 | 103 | 5 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.42e-04 | 53 | 103 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.42e-04 | 158 | 103 | 6 | GO:0030168 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FRAS1 DSCAM PSG3 PSG4 ABCA12 PSG6 LAMB3 CFHR4 SETD2 OLFM3 SLIT1 LRP2 OTOP1 PSG8 LTF MMP13 USH2A | 1.74e-04 | 1269 | 103 | 17 | GO:0009887 |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.76e-04 | 56 | 103 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.86e-04 | 166 | 103 | 6 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 1.98e-04 | 239 | 103 | 7 | GO:0050777 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.31e-04 | 60 | 103 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 2.32e-04 | 509 | 103 | 10 | GO:0032102 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.46e-04 | 61 | 103 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of innate immune response | 2.71e-04 | 519 | 103 | 10 | GO:0045088 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.91e-04 | 116 | 103 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 3.15e-04 | 118 | 103 | 5 | GO:0001570 | |
| GeneOntologyBiologicalProcess | blood coagulation | 3.30e-04 | 260 | 103 | 7 | GO:0007596 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.33e-04 | 66 | 103 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.53e-04 | 67 | 103 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 3.72e-04 | 442 | 103 | 9 | GO:0050878 | |
| GeneOntologyBiologicalProcess | coagulation | 3.79e-04 | 266 | 103 | 7 | GO:0050817 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.96e-04 | 124 | 103 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.96e-04 | 124 | 103 | 5 | GO:0034109 | |
| GeneOntologyBiologicalProcess | hemostasis | 3.96e-04 | 268 | 103 | 7 | GO:0007599 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 4.18e-04 | 70 | 103 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 4.18e-04 | 193 | 103 | 6 | GO:0071902 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 4.26e-04 | 126 | 103 | 5 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 4.58e-04 | 128 | 103 | 5 | GO:0050795 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 4.65e-04 | 72 | 103 | 4 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 4.90e-04 | 73 | 103 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 5.65e-04 | 134 | 103 | 5 | GO:0045638 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 5.71e-04 | 76 | 103 | 4 | GO:0042269 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 6.62e-04 | 382 | 103 | 8 | GO:0043491 | |
| GeneOntologyBiologicalProcess | delamination | 6.78e-04 | 8 | 103 | 2 | GO:0060232 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 6.93e-04 | 80 | 103 | 4 | GO:0002715 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.00e-06 | 16 | 104 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 5.82e-06 | 90 | 104 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | apical plasma membrane | PSG3 PSG4 PSG6 CASR F2RL2 CEACAM21 KCNC2 LRP2 PSG8 OCLN USH2A | 3.11e-05 | 487 | 104 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | LGMN PSG3 PSG4 PSG6 CASR F2RL2 CEACAM21 KCNC2 LRP2 PSG8 OCLN USH2A | 3.84e-05 | 592 | 104 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 4.52e-05 | 335 | 104 | 9 | GO:0061695 | |
| GeneOntologyCellularComponent | cell projection membrane | 5.81e-05 | 431 | 104 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.30e-04 | 98 | 104 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.08e-04 | 170 | 104 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | distal axon | 3.23e-04 | 435 | 104 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.13e-03 | 157 | 104 | 5 | GO:1902554 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.59e-06 | 17 | 83 | 4 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 6.40e-06 | 21 | 83 | 4 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.12e-05 | 24 | 83 | 4 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 1.83e-05 | 27 | 83 | 4 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.12e-05 | 28 | 83 | 4 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.22e-05 | 31 | 83 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.22e-05 | 31 | 83 | 4 | MP:0008964 | |
| MousePheno | abnormal muscle cell glucose uptake | 4.73e-05 | 67 | 83 | 5 | MP:0004130 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 5.26e-05 | 35 | 83 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 5.89e-05 | 36 | 83 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 8.11e-05 | 39 | 83 | 4 | MP:0030022 | |
| MousePheno | abnormal tumor incidence | SMG1 DRD2 SPI1 PSG3 PSG4 PSG6 POLE PTGER2 USP4 PSG8 LTF BECN1 FEM1A | 8.74e-05 | 635 | 83 | 13 | MP:0002019 |
| MousePheno | abnormal tumor susceptibility | SMG1 DRD2 SPI1 PSG3 PSG4 PSG6 POLE PTGER2 USP4 PSG8 LTF BECN1 FEM1A | 1.10e-04 | 650 | 83 | 13 | MP:0002166 |
| MousePheno | neoplasm | SMG1 DRD2 SPI1 PSG3 PSG4 PSG6 POLE PTGER2 APOBEC3F USP4 PSG8 LTF BECN1 FEM1A | 1.17e-04 | 747 | 83 | 14 | MP:0002006 |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.31e-04 | 44 | 83 | 4 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.70e-04 | 47 | 83 | 4 | MP:0031617 | |
| MousePheno | abnormal skin development | 1.83e-04 | 19 | 83 | 3 | MP:0003941 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.00e-04 | 49 | 83 | 4 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 2.71e-04 | 53 | 83 | 4 | MP:0003926 | |
| MousePheno | increased tumor incidence | 2.86e-04 | 530 | 83 | 11 | MP:0002020 | |
| MousePheno | abnormal fatty acid oxidation | 2.92e-04 | 54 | 83 | 4 | MP:0010953 | |
| MousePheno | abnormal cellular glucose uptake | 3.47e-04 | 102 | 83 | 5 | MP:0003925 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 4.38e-04 | 60 | 83 | 4 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 4.66e-04 | 61 | 83 | 4 | MP:0010951 | |
| MousePheno | decreased respiratory quotient | 4.91e-04 | 110 | 83 | 5 | MP:0010379 | |
| MousePheno | abnormal food intake | 5.43e-04 | 481 | 83 | 10 | MP:0005449 | |
| MousePheno | increased insulin secretion | 5.60e-04 | 64 | 83 | 4 | MP:0003058 | |
| MousePheno | increased circulating hormone level | DRD2 PSG3 PSG4 PSG6 KDM5C CASR CEACAM21 DHCR7 LRP2 TNKS PSG8 | 5.94e-04 | 578 | 83 | 11 | MP:0014456 |
| MousePheno | abnormal carbon dioxide production | 6.66e-04 | 67 | 83 | 4 | MP:0008962 | |
| Domain | DUF3398 | 3.22e-06 | 6 | 103 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 3.22e-06 | 6 | 103 | 3 | IPR021816 | |
| Domain | ig | 1.03e-05 | 190 | 103 | 8 | PF00047 | |
| Domain | Immunoglobulin | 1.03e-05 | 190 | 103 | 8 | IPR013151 | |
| Domain | BEACH_dom | 1.34e-05 | 9 | 103 | 3 | IPR000409 | |
| Domain | BEACH | 1.34e-05 | 9 | 103 | 3 | PS50197 | |
| Domain | Beach | 1.34e-05 | 9 | 103 | 3 | PF02138 | |
| Domain | - | 1.34e-05 | 9 | 103 | 3 | 1.10.1540.10 | |
| Domain | Beach | 1.34e-05 | 9 | 103 | 3 | SM01026 | |
| Domain | Ig_V-set | 1.44e-05 | 199 | 103 | 8 | IPR013106 | |
| Domain | DOCK_C | 2.60e-05 | 11 | 103 | 3 | IPR010703 | |
| Domain | DHR-1_domain | 2.60e-05 | 11 | 103 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.60e-05 | 11 | 103 | 3 | PS51651 | |
| Domain | DHR_1 | 2.60e-05 | 11 | 103 | 3 | PS51650 | |
| Domain | DOCK-C2 | 2.60e-05 | 11 | 103 | 3 | PF14429 | |
| Domain | DHR-2 | 2.60e-05 | 11 | 103 | 3 | IPR027357 | |
| Domain | DHR-2 | 2.60e-05 | 11 | 103 | 3 | PF06920 | |
| Domain | DOCK | 2.60e-05 | 11 | 103 | 3 | IPR026791 | |
| Domain | IGc2 | 4.75e-05 | 235 | 103 | 8 | SM00408 | |
| Domain | Ig_sub2 | 4.75e-05 | 235 | 103 | 8 | IPR003598 | |
| Domain | Ig_2 | 5.16e-05 | 73 | 103 | 5 | PF13895 | |
| Domain | V-set | 7.18e-05 | 184 | 103 | 7 | PF07686 | |
| Domain | Lys_sp_deMease-like_dom | 1.79e-04 | 4 | 103 | 2 | IPR013637 | |
| Domain | PLU-1 | 1.79e-04 | 4 | 103 | 2 | PF08429 | |
| Domain | - | BOC FLNC POGLUT3 DSCAM PSG3 PSG4 PSG6 PSG7 FNDC1 CEACAM21 PSG8 USH2A | 2.90e-04 | 663 | 103 | 12 | 2.60.40.10 |
| Domain | zf-C5HC2 | 2.98e-04 | 5 | 103 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 2.98e-04 | 5 | 103 | 2 | IPR004198 | |
| Domain | Ig-like_fold | BOC FLNC POGLUT3 DSCAM PSG3 PSG4 PSG6 PSG7 FNDC1 CEACAM21 PSG8 USH2A | 5.10e-04 | 706 | 103 | 12 | IPR013783 |
| Domain | PH-BEACH_dom | 8.25e-04 | 8 | 103 | 2 | IPR023362 | |
| Domain | - | 8.25e-04 | 8 | 103 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 8.25e-04 | 8 | 103 | 2 | PS51783 | |
| Domain | JmjN | 1.32e-03 | 10 | 103 | 2 | SM00545 | |
| Domain | IG_FLMN | 1.32e-03 | 10 | 103 | 2 | SM00557 | |
| Domain | JMJN | 1.32e-03 | 10 | 103 | 2 | PS51183 | |
| Domain | JmjN | 1.32e-03 | 10 | 103 | 2 | PF02375 | |
| Domain | JmjN | 1.32e-03 | 10 | 103 | 2 | IPR003349 | |
| Domain | Filamin | 1.60e-03 | 11 | 103 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.60e-03 | 11 | 103 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.60e-03 | 11 | 103 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.60e-03 | 11 | 103 | 2 | IPR017868 | |
| Domain | - | 1.89e-03 | 95 | 103 | 4 | 2.60.120.200 | |
| Domain | IG | 2.30e-03 | 421 | 103 | 8 | SM00409 | |
| Domain | Ig_sub | 2.30e-03 | 421 | 103 | 8 | IPR003599 | |
| Domain | - | 3.02e-03 | 15 | 103 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 3.02e-03 | 15 | 103 | 2 | SM00501 | |
| Domain | ARID_dom | 3.02e-03 | 15 | 103 | 2 | IPR001606 | |
| Domain | ARID | 3.02e-03 | 15 | 103 | 2 | PS51011 | |
| Domain | ARID | 3.02e-03 | 15 | 103 | 2 | PF01388 | |
| Domain | PI3/4_kinase_CS | 3.02e-03 | 15 | 103 | 2 | IPR018936 | |
| Domain | - | 3.44e-03 | 16 | 103 | 2 | 1.10.1070.11 | |
| Domain | Laminin_N | 3.44e-03 | 16 | 103 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 3.44e-03 | 16 | 103 | 2 | PS51117 | |
| Domain | Laminin_N | 3.44e-03 | 16 | 103 | 2 | PF00055 | |
| Domain | PI3Kc | 3.44e-03 | 16 | 103 | 2 | SM00146 | |
| Domain | LamNT | 3.44e-03 | 16 | 103 | 2 | SM00136 | |
| Domain | FN3 | 3.62e-03 | 185 | 103 | 5 | SM00060 | |
| Domain | PI3/4_kinase_cat_dom | 4.35e-03 | 18 | 103 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.35e-03 | 18 | 103 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.35e-03 | 18 | 103 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 4.35e-03 | 18 | 103 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.35e-03 | 18 | 103 | 2 | PS00916 | |
| Domain | CBS_dom | 5.36e-03 | 20 | 103 | 2 | IPR000644 | |
| Domain | CBS | 5.36e-03 | 20 | 103 | 2 | PF00571 | |
| Domain | CBS | 5.36e-03 | 20 | 103 | 2 | PS51371 | |
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 1.02e-09 | 16 | 106 | 5 | 11284729 | |
| Pubmed | 1.44e-09 | 17 | 106 | 5 | 16595723 | ||
| Pubmed | 1.44e-09 | 17 | 106 | 5 | 7851895 | ||
| Pubmed | 2.05e-09 | 164 | 106 | 9 | 32409323 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.71e-08 | 13 | 106 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.71e-08 | 13 | 106 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.71e-08 | 13 | 106 | 4 | 16638824 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 20044046 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 32150576 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 6265583 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.71e-08 | 13 | 106 | 4 | 12832451 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.71e-08 | 13 | 106 | 4 | 21670291 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 22162753 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 2702644 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 8380065 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 1279194 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 25724769 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.71e-08 | 13 | 106 | 4 | 22092845 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 11801635 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.71e-08 | 13 | 106 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.71e-08 | 13 | 106 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.71e-08 | 13 | 106 | 4 | 23800882 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 19285068 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 21760897 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.71e-08 | 13 | 106 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.71e-08 | 13 | 106 | 4 | 39168268 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 8402684 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 16619040 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.71e-08 | 13 | 106 | 4 | 8209741 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.71e-08 | 13 | 106 | 4 | 21949477 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 26219866 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 2133556 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 32521208 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 19406938 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.71e-08 | 13 | 106 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.71e-08 | 13 | 106 | 4 | 19358828 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 16680193 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.71e-08 | 13 | 106 | 4 | 34058224 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 10964771 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 32169849 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.71e-08 | 13 | 106 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.71e-08 | 13 | 106 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.71e-08 | 13 | 106 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.71e-08 | 13 | 106 | 4 | 23935487 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 15331748 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 5.71e-08 | 13 | 106 | 4 | 22406619 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 5.71e-08 | 13 | 106 | 4 | 25972571 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 19008452 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 5.71e-08 | 13 | 106 | 4 | 15220458 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 18843289 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 15207636 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 21081647 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 11133662 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 11483763 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 2164599 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 29396368 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 18003729 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 5.71e-08 | 13 | 106 | 4 | 33352461 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 38381498 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 20739537 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 5.71e-08 | 13 | 106 | 4 | 27695943 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 20404914 | ||
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 5.71e-08 | 13 | 106 | 4 | 32027621 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 5.71e-08 | 13 | 106 | 4 | 27777319 | |
| Pubmed | 5.71e-08 | 13 | 106 | 4 | 18848945 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 7.97e-08 | 14 | 106 | 4 | 34666041 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 7.97e-08 | 14 | 106 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 7.97e-08 | 14 | 106 | 4 | 32209360 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 11994468 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 11850617 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 7.97e-08 | 14 | 106 | 4 | 26196244 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 8896983 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 22962327 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 17623671 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 7.97e-08 | 14 | 106 | 4 | 18794798 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 23469261 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 18454175 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 22159884 | ||
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 29907459 | ||
| Interaction | PSG4 interactions | 6.52e-06 | 8 | 100 | 3 | int:PSG4 | |
| Cytoband | 19q13.2 | 1.18e-07 | 164 | 106 | 7 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.20e-10 | 11 | 76 | 5 | 1315 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.89e-06 | 9 | 76 | 3 | 1230 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 6.18e-04 | 163 | 76 | 5 | 590 | |
| GeneFamily | AT-rich interaction domain containing | 1.77e-03 | 15 | 76 | 2 | 418 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.74e-08 | 180 | 105 | 9 | M8239 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.40e-06 | 48 | 105 | 5 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 2.06e-06 | 93 | 105 | 6 | M40279 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 5.92e-06 | 171 | 105 | 7 | M40134 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 8.02e-06 | 32 | 105 | 4 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.16e-05 | 35 | 105 | 4 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 1.29e-05 | 75 | 105 | 5 | MM605 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP | 1.59e-05 | 199 | 105 | 7 | M7766 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.77e-05 | 135 | 105 | 6 | MM965 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.94e-05 | 284 | 105 | 8 | MM987 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 8.32e-05 | 178 | 105 | 6 | M8996 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 9.09e-07 | 136 | 106 | 6 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 160 | 106 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 160 | 106 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 169 | 106 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 175 | 106 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.69e-06 | 192 | 106 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.69e-06 | 192 | 106 | 6 | 8b4bbbadeac70f65378697120c754f10501b5651 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.89e-06 | 193 | 106 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.76e-05 | 65 | 106 | 4 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.76e-05 | 65 | 106 | 4 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-05 | 145 | 106 | 5 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.17e-05 | 152 | 106 | 5 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 158 | 106 | 5 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 158 | 106 | 5 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.01e-05 | 80 | 106 | 4 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 161 | 106 | 5 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.30e-05 | 162 | 106 | 5 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.30e-05 | 162 | 106 | 5 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-05 | 169 | 106 | 5 | 8180aeda13c511260d0542a94156059d558848a7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 171 | 106 | 5 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 172 | 106 | 5 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-05 | 174 | 106 | 5 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 17065d37fd41f04f67282bee00365daa185e8355 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 6e45e1a5a894ca2e4ebc5cdb17fdf79e9e188185 | |
| ToppCell | facs-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 177 | 106 | 5 | 9ff3a77c5c62c8a950c46ca22cd7bde425b84c9a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 187 | 106 | 5 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-05 | 189 | 106 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.37e-05 | 191 | 106 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 191 | 106 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.37e-05 | 191 | 106 | 5 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.60e-05 | 192 | 106 | 5 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 192 | 106 | 5 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.60e-05 | 192 | 106 | 5 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.84e-05 | 193 | 106 | 5 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | fb234d97191c95b7880280c6e4ed5df124ffb0e1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 194 | 106 | 5 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 195 | 106 | 5 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 196 | 106 | 5 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 196 | 106 | 5 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 197 | 106 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 197 | 106 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 198 | 106 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 198 | 106 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 106 | 5 | b8dc5dc9fe3f52be11940d45959134b2a7575a8b | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 199 | 106 | 5 | bbf81fb20da8a28aac024207696c6ea00473a0df | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 199 | 106 | 5 | 90b20fce27739f28609d664475a197eea586e030 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 199 | 106 | 5 | 617fd53c799722879acd8f2fd69b331d82e7bdb9 | |
| ToppCell | Control-Myeloid-TRAM2|Control / Disease group,lineage and cell class （2021.01.30） | 1.14e-04 | 199 | 106 | 5 | 5a08184573e524ce0e2974eed9817354890830a9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| Computational | Neighborhood of EGFR | 4.88e-05 | 32 | 69 | 4 | GNF2_EGFR | |
| Computational | B-cell malignancies expression clusters. | 5.77e-05 | 65 | 69 | 5 | MODULE_291 | |
| Computational | Neighborhood of IGFBP1 | 7.01e-05 | 35 | 69 | 4 | GNF2_IGFBP1 | |
| Computational | Genes in the cancer module 241. | 1.01e-04 | 73 | 69 | 5 | MODULE_241 | |
| Computational | Neighborhood of MMP11 | 1.45e-04 | 42 | 69 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.07e-04 | 46 | 69 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.65e-04 | 49 | 69 | 4 | GNF2_KISS1 | |
| Computational | Genes in the cancer module 174. | 3.49e-04 | 95 | 69 | 5 | MODULE_174 | |
| Computational | Neighborhood of CDKN1C | 6.63e-04 | 27 | 69 | 3 | GNF2_CDKN1C | |
| Drug | AC1L1IPV | 1.51e-06 | 43 | 104 | 5 | CID000004683 | |
| Disease | cD177 antigen measurement | 3.81e-07 | 18 | 101 | 4 | EFO_0021866 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 6.30e-06 | 11 | 101 | 3 | DOID:90 (biomarker_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 6.93e-05 | 4 | 101 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | hair morphology | 1.33e-04 | 29 | 101 | 3 | EFO_0005038 | |
| Disease | Child Development Disorders, Specific | 1.33e-04 | 29 | 101 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.33e-04 | 29 | 101 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 1.48e-04 | 30 | 101 | 3 | C0008073 | |
| Disease | Intellectual Disability | 1.54e-04 | 447 | 101 | 8 | C3714756 | |
| Disease | glioblastoma (is_marker_for) | 4.66e-04 | 44 | 101 | 3 | DOID:3068 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.68e-04 | 195 | 101 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | hemopexin measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0008149 | |
| Disease | Colorectal Carcinoma | 6.92e-04 | 702 | 101 | 9 | C0009402 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 8.83e-04 | 13 | 101 | 2 | OBA_2045159 | |
| Disease | Metabolic Bone Disorder | 1.03e-03 | 14 | 101 | 2 | C0005944 | |
| Disease | basophil measurement | 1.16e-03 | 60 | 101 | 3 | EFO_0803539 | |
| Disease | matrix metalloproteinase 1 measurement | 1.18e-03 | 15 | 101 | 2 | EFO_0010588 | |
| Disease | schizophrenia (biomarker_via_orthology) | 1.18e-03 | 15 | 101 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | Osteopenia | 1.18e-03 | 15 | 101 | 2 | C0029453 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.35e-03 | 16 | 101 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.71e-03 | 18 | 101 | 2 | OBA_2045155 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.88e-03 | 71 | 101 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 2.33e-03 | 21 | 101 | 2 | OBA_2045156 | |
| Disease | systemising measurement | 2.33e-03 | 21 | 101 | 2 | EFO_0010221 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.58e-03 | 166 | 101 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Colorectal Neoplasms | 2.68e-03 | 277 | 101 | 5 | C0009404 | |
| Disease | sphingomyelin measurement | 2.72e-03 | 278 | 101 | 5 | EFO_0010118 | |
| Disease | complement factor H-related protein 3 measurement | 2.75e-03 | 169 | 101 | 4 | EFO_0600056 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.80e-03 | 23 | 101 | 2 | OBA_2045158 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLIYYINQDSESPYH | 116 | O75077 | |
| IITIGYRVYHSYDLP | 126 | Q92903 | |
| HRYYRSPLVQIYEIE | 251 | Q9UGI9 | |
| YSPPHRRTYSSQVIY | 1861 | Q86UK0 | |
| TPYIDYTHLRISYNV | 406 | P41180 | |
| VHLSVVYLPENLYSY | 51 | Q3KPI0 | |
| SDFIPRLVYQYSYSH | 826 | Q9NQ90 | |
| VALQREPAHYFGYVY | 121 | Q8NEG7 | |
| YLYTLQGLYLVYHPV | 316 | Q9UBM7 | |
| STHYYLLPERPSYLE | 856 | Q07912 | |
| YSRLLSLHSPNSYYG | 1976 | Q6ZS30 | |
| PYSFIIGVHGYVLVY | 71 | Q8TAI7 | |
| SYYRGAHGIIVVYDV | 76 | Q9H0U4 | |
| TYYRGTHGVIVVYDV | 76 | Q15286 | |
| TPAATGLYVDQYLYH | 221 | Q16625 | |
| RHPGVFAYVLNYYRT | 106 | Q96PR1 | |
| ALYQGYHSYAVRTTP | 561 | Q9BR39 | |
| SFLTVHVPLYVSYIY | 3466 | Q86XX4 | |
| HVPLYVSYIYVTAPR | 3471 | Q86XX4 | |
| YEYQPLQIETYGPHV | 246 | P51948 | |
| EEILTPTLYHGYYVR | 36 | Q16082 | |
| GEYIYAFVHRIPPSY | 106 | A8MUM7 | |
| QRYRLVPYGNHSYLE | 326 | Q14457 | |
| QLPGERSYHVYYQIL | 321 | A7E2Y1 | |
| RSYHVYYQILSGRKP | 326 | A7E2Y1 | |
| RYLRSYYHPTNLAGI | 41 | P45452 | |
| YDRYVAICRPLHYTT | 121 | P0C623 | |
| ALERYLSIGHPYFYQ | 131 | P43116 | |
| LQYYLTTEVHPELYV | 46 | Q9Y282 | |
| PHLYSVSYYQLSEEL | 1261 | O94915 | |
| TYRVQYTAYEEGVHL | 1311 | Q14315 | |
| QVYYQASLRPYGVTV | 636 | P98164 | |
| YGVTVYHSLRQPYAT | 646 | P98164 | |
| FSYLEPGSIRHIYLY | 1476 | Q07864 | |
| FYAHPRLQDYYVVIL | 321 | Q6UVM3 | |
| YDRYVAVCRPLHYTV | 121 | O76002 | |
| SHPVARYLGSVDYRY | 591 | Q86VP3 | |
| ATESPDTGLYYHRYL | 41 | Q02818 | |
| HYERILYPYELFQSG | 161 | P29375 | |
| PSNIILIIHHANYYY | 316 | O00254 | |
| TIYLEASLHQPLYYL | 51 | P0C7T3 | |
| QELTQHIYTLNGYPY | 91 | O60906 | |
| GYPHEILRYTYDPTF | 51 | Q86YG4 | |
| TAISHGIYYLYPFNI | 261 | Q7RTM1 | |
| PNVTLTISAARLYYY | 111 | Q8IUX4 | |
| QALGYYYVLEPRVVD | 626 | O75173 | |
| RGNIYYQSYEHRSPS | 66 | A2AJT9 | |
| NNTPIHGFYIYYRPT | 741 | Q9BWV1 | |
| SYRNLLYVYPHSLNF | 546 | Q96HP0 | |
| ASYIHYVFRLPNTYP | 846 | Q96N67 | |
| EVYVPHTVYRNLLYV | 551 | Q8NF50 | |
| HTVYRNLLYVYPQRL | 556 | Q8NF50 | |
| PHGSYQSYIDYLRNL | 3776 | Q8TD57 | |
| YEIPATHLYFGRSVS | 306 | Q9UKT7 | |
| QSYVEALPTIQGYYR | 1846 | Q4ZHG4 | |
| ILGPSHPDTSYYIRY | 381 | Q9BSK4 | |
| IQHGHLYYENTRRPY | 276 | Q92496 | |
| GLTHIFSAINPVLYY | 166 | Q3C1V0 | |
| VAGNYYPVNTRIYIT | 771 | O00754 | |
| HYSSPGYVLFYLVRI | 391 | Q92636 | |
| GYHPPSAYYAVSQLR | 231 | Q13751 | |
| HSYYYRPARTGIISL | 41 | A4QMS7 | |
| VAYGLDIYQTRVYPS | 936 | Q8N766 | |
| RSYVVPPAYSAVNYH | 201 | Q92904 | |
| RPHYNYYATLLTLLI | 31 | P14416 | |
| YHYITSYVVDGQRII | 76 | Q00888 | |
| RSLEYAGFHNVYPYT | 326 | Q96PB7 | |
| DHYVAIYNPLLYSVS | 151 | Q8NGG3 | |
| YEQTLAELHRYTPRY | 206 | Q9UKS6 | |
| YGGIRSYPVTLNVLY | 316 | Q16557 | |
| RIYPSFTYYHSGENL | 336 | Q16557 | |
| RIALHTALNNPYYYL | 596 | Q9UBD5 | |
| TYIHCRVIGYPYYSI | 521 | O60469 | |
| TDYDSYLSIRPLYQH | 116 | Q6T310 | |
| GVITHYNIYLHGRLY | 2561 | O75445 | |
| PYNYAVTASSRIHIY | 51 | Q8TED0 | |
| ELLRSYLLVYYPHIV | 111 | O95219 | |
| FHVPEGRIYTVYQLS | 766 | Q6YHU6 | |
| YGTERQPRTHYYAVA | 101 | P02788 | |
| SYVVHGQIIYGPAYS | 81 | Q00889 | |
| YGGIRSYPVTLNVLY | 316 | Q9UQ74 | |
| HFPAIQYAVLYTLYS | 656 | Q96Q15 | |
| LHYTYLDTFGRPVIV | 396 | P04843 | |
| VPYDTDLYQRQTHEY | 21 | P17947 | |
| RIYPSFTYYHSGQNL | 336 | Q13046 | |
| HYLYQRSQPVDYFIL | 546 | Q8NE01 | |
| VNVDGTVAAYRYPYL | 371 | Q7Z4H8 | |
| PYHLSRDLYYLTVES | 101 | Q8N0U2 | |
| FYTEHGLATIYSPYL | 246 | Q32MQ0 | |
| TSRYKLHYYETPTGI | 66 | Q9Y5R8 | |
| RPYVYDLIAVSNHYG | 861 | Q13107 | |
| HLVPTVDYYPDRTYI | 56 | Q8N9B8 | |
| YRYGDIRTYHPPAQL | 3306 | Q96T58 | |
| VIYTDYRPTPLQHYI | 306 | P42285 | |
| VYHSYLTIFGQIPGY | 971 | O94759 | |
| RPSVNGLAYAEYVIY | 1281 | O95271 | |
| RGEQAYPEYLITYQI | 1296 | O95271 | |
| VRDYHIGIPLTYSQY | 431 | Q9H269 | |
| LQVNGRHEYLYGSYP | 241 | O00329 | |
| PSYVHVATELGYLFI | 331 | Q8NDW8 | |
| PEGKIYYYHVITRQT | 2401 | Q9BYW2 | |
| LSYPGTQEQYAVYLR | 26 | Q8IWR0 | |
| PITGTHLYQYRVFGT | 156 | Q9NQZ5 | |
| VERGAVYSSPLYQYL | 791 | Q5QJ38 | |
| VYPLSQDLPYVHIIY | 591 | Q9H6R7 | |
| QLTSGGRPHYYVSYR | 381 | Q8WY21 | |
| LYQGHVRVSYDPGSY | 1216 | O75093 | |
| ATYAAIDPRVQYLGY | 1086 | Q5TAX3 | |
| LTYPLTVYYVITHLV | 481 | Q9H091 | |
| HIARLYGEPVLTYQY | 1301 | Q562E7 | |
| SLLRSHYERIVYPYE | 151 | P41229 | |
| THEAVYPLYTIVFIY | 146 | Q9P055 | |
| PTYEYALRHLYVLVN | 396 | Q99538 |